chr5-81332529-T-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_130767.3(ACOT12):āc.1339A>Cā(p.Lys447Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000696 in 1,614,150 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_130767.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ACOT12 | NM_130767.3 | c.1339A>C | p.Lys447Gln | missense_variant | 13/15 | ENST00000307624.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ACOT12 | ENST00000307624.8 | c.1339A>C | p.Lys447Gln | missense_variant | 13/15 | 1 | NM_130767.3 | P1 | |
ACOT12 | ENST00000506440.1 | n.212A>C | non_coding_transcript_exon_variant | 2/3 | 2 | ||||
ACOT12 | ENST00000508234.5 | n.319A>C | non_coding_transcript_exon_variant | 4/6 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000526 AC: 80AN: 152212Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000493 AC: 124AN: 251398Hom.: 0 AF XY: 0.000486 AC XY: 66AN XY: 135868
GnomAD4 exome AF: 0.000714 AC: 1044AN: 1461820Hom.: 2 Cov.: 30 AF XY: 0.000737 AC XY: 536AN XY: 727224
GnomAD4 genome AF: 0.000525 AC: 80AN: 152330Hom.: 0 Cov.: 32 AF XY: 0.000550 AC XY: 41AN XY: 74498
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 26, 2024 | The c.1339A>C (p.K447Q) alteration is located in exon 13 (coding exon 13) of the ACOT12 gene. This alteration results from a A to C substitution at nucleotide position 1339, causing the lysine (K) at amino acid position 447 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at